Income Taxes (Details) - USD ($) $ in Thousands |
12 Months Ended | |
---|---|---|
Jul. 31, 2023 |
Jul. 31, 2022 |
|
Income Tax Disclosure [Abstract] | ||
Valuation allowance, deferred tax asset, increase (decrease), amount | $ (7,925) | $ 4,736 |
Operating loss carryforwards transaction | the Company had U.S. federal net operating loss carryforwards of approximately $54,025 of which $16,214, if not fully utilized, expire between 2030 and 2038 and which $37,811 do not expire. | |
Net operating loss carryforwards, description | The Company has local net operating loss carryforwards of $1,101 which expire in 2042. Utilization is dependent on generating sufficient taxable income prior to expiration of the tax loss carryforwards.In addition, the Company has research and development tax credit carryforwards of approximately $1,646 which expire between 2025 and 2043. | |
Foreign loss carryforwards | $ 16,574 |
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income. No definition available.
|
X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|